Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Allergan bags an early-stage gene therapy in $60M RetroSense buyout
Allergan bags an early-stage gene therapy in $60M RetroSense buyout
Allergan bags an early-stage gene therapy in $60M RetroSense buyout
Submitted by
admin
on September 6, 2016 - 9:53am
Source:
Endpoints
News Tags:
Allergan
gene therapy
RetroSense Therapeutics
M&A
Headline:
Allergan bags an early-stage gene therapy in $60M RetroSense buyout
Do Not Allow Advertisers to Use My Personal information
